Johnson & Johnson (JNJ)
218.55
+4.90
(+2.29%)
USD |
NYSE |
Jan 14, 16:00
217.90
-0.65
(-0.30%)
Pre-Market: 08:02
Johnson & Johnson Research and Development Expense (Quarterly): 3.693B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.90B |
| Gilead Sciences, Inc. | 1.334B |
| Eli Lilly & Co. | 3.466B |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Protagonist Therapeutics, Inc. | 40.00M |